obesity

Allergan Agrees to Sell Obesity Unit; 3rd-Quarter Profit Up 20%
NASDAQ.com
Tue, 10/29/13 - 10:02 am
Allergan
obesity
earnings
M&A
Apollo Endosurgery
Arena's Belviq Sales Flat - Equity Holds
Seeking Alpha
Fri, 10/18/13 - 06:16 pm
Belviq
obesity
Eisai
Arena Pharmaceuticals
Vivus Outlines Key Data Points
Seeking Alpha
Wed, 10/16/13 - 09:31 am
Vivus
obesity
Qsymia
Arena - Tracking Belviq Refills
Seeking Alpha
Tue, 10/8/13 - 08:41 am
Belviq
Eisai
Arena Pharmaceuticals
obesity
[video]Can This Obesity-Drug Maker Beat Arena and VIVUS in Europe?
Motley Fool
Mon, 10/7/13 - 09:12 am
obesity
Europe
Vivus
Arena Pharmaceuticals
Belviq
Qsymia
Contrave
Orexigen
Arena's Belviq Sales Pass 4,000 On IMS
Seeking Alpha
Sat, 10/5/13 - 09:29 am
Arena
Belviq
obesity
weight loss
Orexigen obesity drug Contrave filed in Europe
Pharma Times, UK
Fri, 10/4/13 - 10:16 am
Orexigen
Europe
Contrave
obesity
Obesity drug makers jockey for position as analysts praise Vivus
Marketwatch
Thu, 10/3/13 - 05:29 pm
obesity
Vivus
Belviq
Arena Pharmaceuticals
Contrave
Orexigen
Qsymia
VIVUS' Hopes Tied to Qsymia
Yahoo/Zacks
Thu, 09/26/13 - 08:51 am
Vivus
Qsymia
obesity
Sanofi settles suit over obesity drug, Bloomberg says
Bloomberg
Fri, 09/20/13 - 09:29 am
Sanofi
obesity
Zimulti
Update on Arena/Eisai's Belviq
Yahoo/Zacks
Wed, 09/18/13 - 11:39 am
Arena Pharmaceuticals
Belviq
obesity
Eisai
Advertising Starts On Arena's Belviq
Seeking Alpha
Mon, 09/16/13 - 10:15 am
drug ads
Arena Pharmaceuticals
Belviq
obesity
Eisai
Is Vivus a Rudderless Ship?
Motley Fool
Sat, 09/14/13 - 10:47 am
Vivus
Qsymia
Arena Pharmaceuticals
Belviq
obesity
weight loss
Vivus' Qsymia Scripts Remain Flat
Seeking Alpha
Mon, 09/9/13 - 09:55 am
obesity
Arena Pharmaceuticals
Belviq
Eisai
Vivus
Qsymia
Anthony Zook
Assessing Arena's Belviq Sales After 3 Months
Seeking Alpha
Mon, 09/9/13 - 09:54 am
obesity
Arena Pharmaceuticals
Belviq
Eisai
Vivus
Qsymia
Arena's Belviq Prescriptions Flat Week Over Week
Seeking Alpha
Sat, 09/7/13 - 12:11 pm
Arena Pharmaceuticals
Belviq
obesity
weight loss
Third Obesity Drug Moves Closer to FDA Approval
Motley Fool
Thu, 08/29/13 - 05:05 pm
obesity
FDA
Orexigen
Contrave
Belviq
Qsymia
Vivus
Arena Pharmaceuticals
Zealand Pharma, Eli Lilly sign obesity, diabetes research deal
Reuters
Thu, 08/29/13 - 09:31 am
Eli Lilly
Zealand Pharma
obesity
diabetes
R&D
Orexigen Readies New Drug Application
Seeking Alpha
Tue, 08/27/13 - 10:56 am
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Belviq
Qsymia
Vivus
New entrant in obesity drug race targets body, not the mind
Reuters
Sat, 08/24/13 - 11:35 am
Zafgen
obesity
weight loss. Beloranib

Pages